New Microbiologica

Scope & Guideline

Elevating knowledge in the dynamic field of Microbiology.

Introduction

Welcome to your portal for understanding New Microbiologica, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1121-7138
PublisherEDIZIONI INT SRL
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1993 to 2024
AbbreviationNEW MICROBIOL / New Microbiol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA SPADOLINI 7, MILANO 20141, ITALY

Aims and Scopes

The journal 'New Microbiologica' is dedicated to the dissemination of research on diverse aspects of microbiology, particularly focusing on infectious diseases, antimicrobial resistance, and the interplay between pathogens and hosts. Its comprehensive approach includes clinical studies, laboratory research, and public health implications, making it a vital resource for researchers and healthcare professionals alike.
  1. Infectious Diseases and Epidemiology:
    The journal emphasizes the study of infectious diseases, including their epidemiology, clinical features, and outcomes. Research often focuses on the prevalence and impact of various pathogens in different populations.
  2. Antimicrobial Resistance:
    A significant theme in the journal is the exploration of antimicrobial resistance patterns among various pathogens, helping to inform treatment strategies and public health initiatives.
  3. Clinical Microbiology and Diagnostics:
    The journal publishes studies on the diagnostic methods for identifying pathogens, including innovations in laboratory techniques and their application in clinical settings.
  4. Host-Pathogen Interactions:
    Research on the interactions between pathogens and their hosts is a core area, providing insights into disease mechanisms and potential therapeutic targets.
  5. Innovative Therapeutic Approaches:
    The journal highlights novel treatment strategies, including combination therapies and the use of new antimicrobial agents, reflecting ongoing efforts to combat resistant infections.
  6. Public Health and Policy Implications:
    Studies that connect microbiological research with public health policy are prevalent, addressing issues such as vaccination strategies, infection control measures, and health education.
The journal 'New Microbiologica' has seen the rise of several emerging themes in recent years, reflecting current challenges and advancements in microbiological research. These trends indicate the journal's responsiveness to global health issues and scientific innovations.
  1. COVID-19 and Associated Infections:
    Research related to COVID-19, including its clinical impact, co-infections, and long-term effects, has surged, highlighting the pandemic's influence on current microbiological research priorities.
  2. Molecular Epidemiology and Genomic Studies:
    There is a growing trend towards genomic epidemiology, with studies focusing on the genetic characterization of pathogens, particularly in relation to antibiotic resistance and outbreak investigations.
  3. Innovations in Antimicrobial Susceptibility Testing:
    Recent publications emphasize advancements in antimicrobial susceptibility testing methodologies, reflecting a need for rapid and accurate diagnostics in clinical microbiology.
  4. Viral Infections and Co-Infections:
    The investigation of viral pathogens, particularly their interactions with other pathogens and their role in disease severity, has gained prominence, especially in the context of respiratory viruses.
  5. Public Health Strategies for Infection Control:
    Emerging themes include public health strategies aimed at controlling infectious diseases, with an emphasis on vaccination, surveillance, and health policy to mitigate outbreaks.

Declining or Waning

While the journal covers a broad range of topics in microbiology, certain themes have shown a decline in publication frequency, reflecting shifts in research focus and emerging priorities within the field.
  1. Traditional Antibiotic Studies:
    There appears to be a waning interest in studies solely focused on traditional antibiotics without consideration of resistance patterns or combination therapies, as the field moves towards a more integrated approach to antimicrobial treatment.
  2. Basic Laboratory Techniques:
    Papers focusing exclusively on basic microbiological laboratory techniques are becoming less common as the field emphasizes more complex methodologies and technologies, such as molecular diagnostics and next-generation sequencing.
  3. Non-Infectious Microbial Studies:
    Research that does not directly relate to infectious diseases, such as studies on microbiomes in non-clinical settings, is less frequently published, possibly in favor of more clinically relevant microbiological research.

Similar Journals

Klimik Journal

Advancing Infectious Disease Insights.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 1301-143XFrequency: 4 issues/year

Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.

Infectious Diseases and Clinical Microbiology

Uniting scholars to combat infectious diseases worldwide.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Microbiology Research

Pioneering Discoveries in Microbial Research
Publisher: MDPIISSN: Frequency: 4 issues/year

Microbiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.

MIKROBIYOLOJI BULTENI

Elevating Scientific Discourse in Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Reviews and Research in Medical Microbiology

Delivering High-Impact Research for Healthcare Professionals
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

INFECTION

Transforming Research into Real-World Solutions
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Mediterranean Journal of Infection Microbes and Antimicrobials

Exploring the intricate world of microbes and health.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

BMC MICROBIOLOGY

Connecting minds through groundbreaking microbiology insights.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Championing Open Access to Medical Microbiology Insights
Publisher: ELSEVIER GMBHISSN: 1438-4221Frequency: 8 issues/year

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

CLINICAL MICROBIOLOGY AND INFECTION

Bridging Gaps in Clinical Microbiology
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.